Merck (MRK) Divestments (2009 - 2021)

Merck (MRK) posted quarterly Divestments of -$82.0 million for Q2 2021, down 57.69% sequentially from -$52.0 million in Q1 2021.

Merck (MRK) Divestments (2009 - 2021) Analysis & Trends

Merck has disclosed Divestments across 7 years of filings, most recently posting -$82.0 million for Q2 2021.

In Q2 2021, Divestments changed N/A year-over-year to -$82.0 million; the TTM figure through Mar 2022 stood at -$82.0 million (up 59.41% YoY), while the FY2021 annual figure was -$134.0 million, up 46.4% from the prior year.
Divestments fell to -$82.0 million in Q2 2021, from -$52.0 million in the prior quarter.
Over the last five years, Divestments for MRK reached as high as -$52.0 million in Q1 2021 and fell as low as -$82.0 million in Q2 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	-
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	-
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	-
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	-
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	-
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	-
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	-
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	-
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-2.00 Mn
10	Biogen	30.87 Bn	26.59 Bn	1.82 Bn	-

Historic Data

Download Data

Date	Value
Jun 30, 2021	-82.00 Mn
Mar 31, 2021	-52.00 Mn
Dec 31, 2020	-81.00 Mn
Sep 30, 2020	-69.00 Mn
Dec 31, 2015	170.00 Mn
Sep 30, 2015	126.00 Mn
Jun 30, 2015	25.00 Mn
Dec 31, 2014	600.00 Mn
Jun 30, 2014	419.00 Mn
Mar 31, 2014	533.00 Mn
Dec 31, 2013	172.00 Mn
Dec 31, 2011	-148.00 Mn
Sep 30, 2011	175.00 Mn
Jun 30, 2011	17.00 Mn
Mar 31, 2011	306.00 Mn
Sep 30, 2009	4.00 Bn